How many drugs treat Enterobacter Infection?

Drug Landscape tracks 3 marketed treatments for Enterobacter Infection (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/enterobacter-infection.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Enterobacter Infection — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Enterobacter Infection (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Enterobacter Infection, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Coly-Mycin M	COLISTIMETHATE SODIUM	Ph Health	Polymyxin-class Antibacterial		1970-01-01
Coly-Mycin S	COLISTIN	Par Sterile Products	colistin	Melanocortin receptor 3	1962-01-01
colimycin	colimycin	Poitiers University Hospital		Melanocortin receptor 3, Melanocortin receptor 5, Epidermal growth factor receptor

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Par Sterile Products · 1 drug in Enterobacter Infection
Ph Health · 1 drug in Enterobacter Infection
Poitiers University Hospital · 1 drug in Enterobacter Infection

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Enterobacter Infection:

Cite this brief

Drug Landscape (2026). Enterobacter Infection — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/enterobacter-infection. Accessed 2026-06-10.

Enterobacter Infection full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing